Results 1 to 10 of about 367,035 (204)

Combined effect of serum carcinoembryonic antigen and hepatic steatosis on new-onset ischemic heart disease among middle-aged and older Korean adults: a cohort study

Frontiers in Nutrition, 2023
BackgroundCarcinoembryonic antigen (CEA) is a commonly used tumor marker in cancer screening. However, it has also been associated with metabolic alterations.
Ji Won Kwak, Yong Jae Lee, Byoungjin Park, Dong Hyuk Jung   +3 more
doaj   +1 more source

Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018

Frontiers in Immunology, 2022
BackgroundAs a novel inflammatory marker, Systemic Immune-Inflammation Index (SII) has not been studied with hepatic steatosis. The aim of this study was to investigate the possible relationship between SII and hepatic steatosis.MethodsIn the cross ...
Yancheng Song, Wencong Guo, Zhaopeng Li, Dong Guo, Zhao Li, Yu Li   +5 more
doaj   +1 more source

The Associations of Anthropometric Parameters and Hepatic Steatosis [PDF]

Journal of Fasting and Health, 2020
Introduction: Non-alcoholic fatty liver disease (NAFLD) is an important health problem globally that characterized as a disease spectrum which includes simple steatosis, non-alcoholic steatohepatitis and liver fibrosis and cirrhosis.
Maryam Ghandehari, Zahra Dehnavi, Farkhondeh Razmpour, Mahsa Miryan, Davood Soleimani, Seyed Mostafa Parizadeh, Reza Jafarzadeh Esfehani, Majid Sedaghat, Habibollah Esmaily, Mohsen Nematy   +9 more
doaj   +1 more source

Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients

Frontiers in Oncology, 2021
Purpose: Colorectal liver metastasis (CRLM) is the major cause of death due to colorectal cancer. Although great efforts have been made in treatment of CRLM, about 60–70% of patients will develop hepatic recurrence.
Haiyan Chen, Haiyan Chen, Siqi Dai, Siqi Dai, Yimin Fang, Yimin Fang, Liubo Chen, Liubo Chen, Kai Jiang, Kai Jiang, Qichun Wei, Qichun Wei, Kefeng Ding, Kefeng Ding   +13 more
doaj   +1 more source

Comparison of 1H-magnetic resonance spectroscopy and blood biochemistry as methods for monitoring non-diffuse hepatic steatosis in a rat model

Toxicology Reports, 2023
No method of monitoring drug-induced hepatic steatosis has been established, which is a concern in drug development. Hepatic steatosis is divided into diffuse and non-diffuse forms according to the pattern of fat deposition. Diffuse hepatic steatosis was
Yuka Yoshino, Yuta Fujii, Kazuhiro Chihara, Aya Nakae, Jun-ichiro Enmi, Yoshichika Yoshioka, Izuru Miyawaki   +6 more
doaj   +1 more source

Hepatic steatosis is associated with dysregulated cholesterol metabolism and altered protein acetylation dynamics in chickens

Journal of Animal Science and Biotechnology, 2023
Background Hepatic steatosis is a prevalent manifestation of fatty liver, that has detrimental effect on the health and productivity of laying hens, resulting in economic losses to the poultry industry.
Xiaoli Guo, Qianqian Zhou, Jiaming Jin, Fangren Lan, Chaoliang Wen, Junying Li, Ning Yang, Congjiao Sun   +7 more
doaj   +1 more source

Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study [PDF]

Endocrinology and Metabolism, 2023
Background Fatty liver is associated with increased risk of developing type 2 diabetes. We aimed to evaluate whether the severity of hepatic steatosis is associated with incident diabetes.
Ji Min Han, Jung Hwan Cho, Hye In Kim, Sunghwan Suh, Yu-Ji Lee, Jung Won Lee, Kwang Min Kim, Ji Cheol Bae   +7 more
doaj   +1 more source

Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population

Diagnostics, 2021
The noninvasive diagnosis of hepatic steatosis is of increasing concern. This study investigated the association of hepatic steatosis determined by non-enhanced CT criteria with clinical parameters in a screening population.
Jieun Chung, Hee-Sun Park, Young-Jun Kim, Mi-Hye Yu, Sungeun Park, Sung-Il Jung   +5 more
doaj   +1 more source

Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia.

PLoS ONE, 2022
The prevalence of colorectal neoplasm in patients with non-alcoholic fatty liver disease has increased twice as high as that in the general population. FibroScan is a new modality for evaluating hepatic steatosis.
Kwang Woo Kim, Hyoun Woo Kang, Hosun Yoo, Yukyung Jun, Hyun Jung Lee, Jong Pil Im, Ji Won Kim, Joo Sung Kim, Seong-Joon Koh, Yong Jin Jung   +9 more
doaj   +1 more source

Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT. [PDF]

PLoS ONE, 2015
Nonalcoholic fatty liver disease is associated with a risk of coronary artery disease (e.g., diabetes mellitus, dyslipidemia, metabolic syndrome). We evaluated whether nonalcoholic hepatic steatosis is associated with high-risk plaques as assessed by ...
Kazuhiro Osawa, Toru Miyoshi, Kentarou Yamauchi, Yasushi Koyama, Kazufumi Nakamura, Shuhei Sato, Susumu Kanazawa, Hiroshi Ito   +7 more
doaj   +1 more source